Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Real-Time qPCR-Based Detection of Circulating Tumor Cells from Blood Samples of Adjuvant Breast Cancer Patients: A Preliminary Study.

Andergassen U, Zebisch M, Kölbl AC, König A, Heublein S, Schröder L, Hutter S, Friese K, Jeschke U.

Breast Care (Basel). 2016 Jun;11(3):194-8. doi: 10.1159/000447041. Epub 2016 Jun 15.

2.

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.

Tachtsidis A, McInnes LM, Jacobsen N, Thompson EW, Saunders CM.

Clin Exp Metastasis. 2016 Aug;33(6):521-50. doi: 10.1007/s10585-016-9796-8. Epub 2016 May 17. Review.

3.

Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review.

Cebotaru CL, Olteanu ED, Antone NZ, Buiga R, Nagy V.

Clujul Med. 2016;89(2):203-11. doi: 10.15386/cjmed-570. Epub 2016 Apr 15. Review.

4.

Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer.

Yamaguchi T, Okumura T, Hirano K, Watanabe T, Nagata T, Shimada Y, Tsukada K.

World J Surg Oncol. 2016 Feb 20;14(1):40. doi: 10.1186/s12957-016-0793-9.

5.

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer.

Li Y, Gong J, Zhang Q, Lu Z, Gao J, Li Y, Cao Y, Shen L.

Br J Cancer. 2016 Jan 19;114(2):138-45. doi: 10.1038/bjc.2015.417.

PMID:
26784122
6.

The expression of CK-19 gene in circulating tumor cells of blood samples of metastatic breast cancer women.

Soltani S, Mokarian F, Panjehpour M.

Res Pharm Sci. 2015 Nov-Dec;10(6):485-96.

7.

Capture and Identification of Heterogeneous Circulating Tumor Cells Using Transparent Nanomaterials and Quantum Dots-Based Multiplexed Imaging.

Chen YY, Cheng BR, He ZB, Wang SY, Wang ZM, Sun M, Song HB, Fang Y, Chen FF, Xiong B.

J Cancer. 2016 Jan 1;7(1):69-79. doi: 10.7150/jca.12722. eCollection 2016.

8.

Multi-Dimensional Nanostructures for Microfluidic Screening of Biomarkers: From Molecular Separation to Cancer Cell Detection.

Ng E, Chen K, Hang A, Syed A, Zhang JX.

Ann Biomed Eng. 2016 Apr;44(4):847-62. doi: 10.1007/s10439-015-1521-2. Epub 2015 Dec 21. Review.

PMID:
26692080
9.

Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells.

Dickey DD, Giangrande PH.

Methods. 2016 Mar 15;97:94-103. doi: 10.1016/j.ymeth.2015.11.020. Epub 2015 Nov 26. Review.

PMID:
26631715
10.

Screening and Molecular Analysis of Single Circulating Tumor Cells Using Micromagnet Array.

Huang YY, Chen P, Wu CH, Hoshino K, Sokolov K, Lane N, Liu H, Huebschman M, Frenkel E, Zhang JX.

Sci Rep. 2015 Nov 5;5:16047. doi: 10.1038/srep16047.

11.

Real-time Detection of Breast Cancer Cells Using Peptide-functionalized Microcantilever Arrays.

Etayash H, Jiang K, Azmi S, Thundat T, Kaur K.

Sci Rep. 2015 Oct 5;5:13967. doi: 10.1038/srep13967.

12.

Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers.

Kolostova K, Spicka J, Matkowski R, Bobek V.

Am J Transl Res. 2015 Jul 15;7(7):1203-13. eCollection 2015.

13.

Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.

Wu YM, Chen ZJ, Liu H, Wei WD, Lu LL, Yang XL, Liang WT, Liu T, Liu HL, Du J, Wang HS.

Oncotarget. 2015 Sep 22;6(28):25588-601. doi: 10.18632/oncotarget.4436.

14.

Nanotechnology for enrichment and detection of circulating tumor cells.

Bhana S, Wang Y, Huang X.

Nanomedicine (Lond). 2015 Jul;10(12):1973-90. doi: 10.2217/nnm.15.32. Review.

15.

Micro- and nanotechnology approaches for capturing circulating tumor cells.

Panchapakesan B, Caprara R, Velasco V, Loomis J, King B, Xu P, Burkhead T, Sethu P, Stallons LJ, McGregor WG, Rai SN, Kloecker G, Wickstrom E.

Cancer Nanotechnol. 2010;1(1-6):3-11. Epub 2010 Oct 19. Review.

16.

Circulating tumor cells in oral squamous cell carcinoma-an enigma or reality?

Anitha N, Jimson S, Masthan KM, Jacobina JJ.

J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S173-5. doi: 10.4103/0975-7406.155893. Review.

17.

Performance of computer vision in vivo flow cytometry with low fluorescence contrast.

Markovic S, Li S, Niedre M.

J Biomed Opt. 2015 Mar;20(3):035005. doi: 10.1117/1.JBO.20.3.035005.

18.

FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.

Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E, Nagaraju GP, Havel L, Marcus A, Nahta R, O'Regan R.

Oncotarget. 2015 Mar 10;6(7):4757-72.

19.

Rapid inertial solution exchange for enrichment and flow cytometric detection of microvesicles.

Dudani JS, Gossett DR, Tse HT, Lamm RJ, Kulkarni RP, Carlo DD.

Biomicrofluidics. 2015 Feb 5;9(1):014112. doi: 10.1063/1.4907807. eCollection 2015 Jan.

20.

The systematic study of circulating tumor cell isolation using lithographic microfilters.

Adams DL, Zhu P, Makarova OV, Martin SS, Charpentier M, Chumsri S, Li S, Amstutz P, Tang CM.

RSC Adv. 2014;9:4334-4342.

Items per page

Supplemental Content

Write to the Help Desk